14 Results for "

seizure syndrome

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "seizure syndrome" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-B0495
CAS No.: 84057-84-1
Synonyms: LTG; BW430C
Research Areas:  

Neurological Disease Cancer

Lamotrigine (BW430C) is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine selectively blocks voltage-gated Na + channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine can be used for the research of epilepsy, focal seizure, et al .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1237
CAS No.: 127869-51-6
C-Type Natriuretic Peptide (CNP) (1-22), human, a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1237A
CAS No.: 1966153-17-2
C-Type Natriuretic Peptide (CNP) (1-22), human (TFA),a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human (TFA) inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor .
loading...
    loading...
Cat. No.: HY-148410A
CAS No.: 2415330-05-9
Purity:  98.25%
Synonyms: STK-001 sodium
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Zorevunersen sodium is an antisense oligonucleotide targeting the Scn1a gene based on TANGO technology. Zorevunersen sodium increases Scn1a mRNA transcripts and elevates the expression level of NaV1.1 protein. Zorevunersen sodium restores the excitability of PV interneurons, thereby reducing seizures and prolonging survival in mice. Zorevunersen sodium can be used for research on Dravet syndrome .
loading...
    loading...
Cat. No.: HY-101248
CAS No.: 185259-85-2
Purity:  99.86%
Target:  

5-HT Receptor

Research Areas:  

Cancer

GR-46611 is a 5-HT1D receptor agonist. GR-46611 can be used in the research of bladder hyperactivity, leukemia .
loading...
    loading...
Cat. No.: HY-12783A
CAS No.: 733717-87-8
Purity:  ≥98.0%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

SCH 50911 is a selective, orally active, blood-brain barrier permeable GABA-B receptor (GABA-B Receptor) antagonist with an IC50 of 1.1 μM in rats. SCH 50911 blocks baclofen-induced antitussive effects, regulates neuronal firing and GABA release. SCH 50911 promotes spontaneous seizures during withdrawal in ethanol-dependent rats, alters reward-related neurotransmission, and reduces or suppresses lever responding and self-administration behaviors of alcohol and sucrose in rats. SCH 50911 is applicable to research related to ethanol withdrawal syndrome, absence epilepsy and alcohol use disorder .
loading...
    loading...
Cat. No.: HY-148410
CAS No.: 2415330-04-8
Synonyms: STK-001
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Zorevunersen is an antisense oligonucleotide targeting the Scn1a gene based on TANGO technology. Zorevunersen increases Scn1a mRNA transcripts and elevates the expression level of NaV1.1 protein. Zorevunersen restores the excitability of PV interneurons, thereby reducing seizures and prolonging survival in mice. Zorevunersen can be used for research on Dravet syndrome .
loading...
    loading...
Cat. No.: HY-P5183
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Hm1a is a venom peptide and a selective hNaV1.1 activator with an EC50 of 7.5 nM. Hm1a enhances hNaV1.1 and hNaV1.3 channel currents via delayed inactivation. Hm1a restores action potential firing in Dravet syndrome GABAergic inhibitory interneurons, reduces interictal epileptiform discharges and whole-brain hyperexcitability, lowers seizure frequency, and rescues premature death in Dravet syndrome mice. Hm1a can be used for the research of neurological disease, such as Dravet syndrome .
loading...
    loading...
Cat. No.: HY-W773779
CAS No.: 748145-12-2
Target:  

GSK-3

GSK3-IN-9 (Compound 0713) is a selective glycogen synthase kinase 3 (GSK3) inhibitor. GSK3-IN-9 Fragile X syndrome, attention deficit hyperactivity disorder (ADHD), childhood seizure, intellectual disability, diabetes, acute myeloid leukemia (AML), autism, and psychiatric disorder .
loading...
    loading...
Cat. No.: HY-10049
CAS No.: 145742-28-5
CP 122721 is an orally active NK1 receptor antagonist. CP 122721 attenuates cisplatin-induced vomiting in ferrets (ID50: 0.08 mg/kg). CP 122721 inhibits kainate (KA)-induced seizure activity and CA1 neuronal cell death in rats. CP 122721 is useful in the study of depression, asthma, and irritable bowel syndrome (IBS) .
loading...
    loading...
Cat. No.: HY-155093
CAS No.: 3033124-61-4
Target:  

GLUT

Research Areas:  

Neurological Disease

GLUT1-IN-3 (Compd 4b), an investigational compound associated with type 1 glucose transporter deficiency syndrome, potently suppresses seizures .
loading...
    loading...
Cat. No.: HY-B0495A
CAS No.: 375347-20-9
Synonyms: LTG hydrate; BW430C hydrate
Research Areas:  

Neurological Disease Cancer

Lamotrigine hydrate is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine hydrate selectively blocks voltage-gated Na + channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine hydrate can be used for the research of epilepsy, focal seizure, et al .
loading...
    loading...
Cat. No.: HY-B0495S6
Synonyms: LTG-13C2,15N2,d3; BW430C-13C2,15N2,d3
Lamotrigine- 13C2, 15N2,d3 is 15N and deuterated labeled Lamotrigine (HY-B0495). Lamotrigine (BW430C) is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine selectively blocks voltage-gated Na + channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine can be used for the research of epilepsy, focal seizure, et al .
loading...
    loading...
Cat. No.: HY-12783
CAS No.: 160415-07-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

SCH 50911 dihydrochloride is a selective, orally active, blood-brain barrier permeable GABA-B receptor (GABA-B Receptor) antagonist with an IC50 of 1.1 μM in rats. SCH 50911 dihydrochloride blocks baclofen-induced antitussive effects, regulates neuronal firing and GABA release. SCH 50911 dihydrochloride promotes spontaneous seizures during withdrawal in ethanol-dependent rats, alters reward-related neurotransmission, and reduces or suppresses lever responding and self-administration behaviors of alcohol and sucrose in rats. SCH 50911 dihydrochloride is applicable to research related to ethanol withdrawal syndrome, absence epilepsy and alcohol use disorder .
loading...
    loading...
  • 1